Your browser doesn't support javascript.
loading
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.
Rossignol, Julien; Georgin-Lavialle, Sophie; Canioni, Danielle; Beganovic, Omer; Brouzes, Chantal; Fain, Olivier; Heiblig, Maël; Gourguechon, Clément; Guilpain, Philippe; Bulai-Livideanu, Cristina; Barete, Stéphane; Agopian, Julie; Brenet, Fabienne; Dubreuil, Patrice; Lemal, Richard; Tournilhac, Olivier; Terriou, Louis; Launay, David; Bouillet, Laurence; Chatain, Catharina; Damaj, Ghandi; Ballul, Thomas; Greco, Celine; Polivka, Laura; Frenzel, Laurent; Meni, Cécile; Bouktit, Hassiba; Benabou, Dina; Devin, Clotilde; Gaudy-Marqueste, Caroline; Gousseff, Marie; Le Mouel, Edwige; Neel, Antoine; Ranta, Dana; Jaussaud, Roland; Jo Molina, Thierry; Bruneau, Julie; Javier, Rose-Marie; Pelletier, Fabien; Castelain, Florence; Retornaz, Frederique; Cabrera, Quentin; Zunic, Patricia; Gourin, Marie Pierre; Wierzbicka-Hainaut, Ewa; Viallard, Jean François; Lavigne, Christian; Hoarau, Cyrille; Durieu, Isabelle; Dimicoli-Salazar, Sophie.
Afiliación
  • Rossignol J; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Georgin-Lavialle S; Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris.
  • Canioni D; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
  • Beganovic O; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
  • Brouzes C; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
  • Fain O; Department of Internal Medicine, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris.
  • Heiblig M; CEREMAST, Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite.
  • Gourguechon C; Department of Hematology, Amiens University Hospital, Amiens.
  • Guilpain P; CEREMAST, Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier.
  • Bulai-Livideanu C; CEREMAST, Department of Dermatology, Hôpital Larrey, CHU Toulouse, Toulouse.
  • Barete S; CEREMAST, Dermatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris.
  • Agopian J; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
  • Brenet F; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
  • Dubreuil P; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
  • Lemal R; CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.
  • Tournilhac O; CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.
  • Terriou L; CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille.
  • Launay D; CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille, France; Lille University, INSERM U995 LIRIC, CHU Lille, and Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille.
  • Bouillet L; CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.
  • Chatain C; CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.
  • Damaj G; CEREMAST, Hematology Institute, Normandy University School of Medicine, Caen.
  • Ballul T; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Greco C; CEREMAST, Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
  • Polivka L; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Frenzel L; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Meni C; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Bouktit H; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Benabou D; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Devin C; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
  • Gaudy-Marqueste C; CEREMAST, Department of Dermatology, Aix-Marseille University, CHU Timone, Marseille.
  • Gousseff M; Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes.
  • Le Mouel E; CEREMAST, Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes.
  • Neel A; CEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes.
  • Ranta D; Department of Hematology, Nancy University Hospital, Nancy.
  • Jaussaud R; Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy.
  • Jo Molina T; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
  • Bruneau J; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
  • Javier RM; CEREMAST, Department of Rheumatology, Strasbourg University Hospital, Strasbourg.
  • Pelletier F; CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.
  • Castelain F; CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.
  • Retornaz F; Unité de soins et de recherche en médecine interne et maladies infectieuses, European hospital, Marseille.
  • Cabrera Q; Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.
  • Zunic P; Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.
  • Gourin MP; CEREMAST, Department of Hematology, CHU Dupuytren, Limoges.
  • Wierzbicka-Hainaut E; CEREMAST, Department of Dermatology, CHU de Poitiers, Poitiers.
  • Viallard JF; Department of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux; Bordeaux University, Bordeaux.
  • Lavigne C; CEREMAST, Department of Internal Medicine and Clinical Immunology, University Hospital, Angers.
  • Hoarau C; CEREMAST, Department of Clinical Immunology and Allergology, CHRU Tours, Tours.
  • Durieu I; CEREMAST, Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon.
  • Dimicoli-Salazar S; Department of Hematology, CHU Bordeaux, Bordeaux.
Haematologica ; 2024 Aug 29.
Article en En | MEDLINE | ID: mdl-39219498
ABSTRACT
Not available.
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article Pais de publicación: Italia